enorm
speed
unpreced
intern
collabor
coordin
novel
coronaviru
caus
sar
term
sarscov
isol
character
allow
develop
diagnost
test
first
sar
epidem
still
full
swing
sever
acut
respiratori
syndrom
sar
laboratori
diagnost
test
april
http
wwwwhointcsrsarsdiagnostictestsen
earli
midapril
sequenc
polymeras
chain
reaction
pcr
primer
made
publicli
avail
sar
websit
pcr
primer
sar
develop
network
laboratori
april
http
wwwwhointcsrsarsprimersen
facilit
introduct
laboratori
test
affect
countri
soon
afterward
first
commerci
assay
becam
avail
numer
laboratori
world
start
prepar
sar
diagnosi
use
variou
inhous
assay
import
research
effort
still
april
direct
toward
improv
sar
laboratori
test
includ
develop
novel
genom
target
nucleic
acid
detect
recombin
antigen
serolog
diagnosi
nevertheless
despit
effort
recogn
laboratori
diagnosi
sar
far
remain
problemat
problem
test
specif
led
falseposit
result
sarscov
occas
creat
enorm
public
concern
confus
addit
result
newli
develop
antibodi
test
yield
result
difficult
reconcil
epidemiolog
inform
may
relat
insuffici
test
sensit
specif
chapter
endeavour
briefli
list
describ
current
avail
laboratori
test
method
sarscov
includ
perform
far
publish
outlin
current
whoendors
strategi
laboratori
diagnosi
suspect
sar
wolfgang
preiser
christian
drosten
han
wilhelm
doerr
case
includ
recommend
deal
case
provid
outlook
regard
futur
develop
contrast
previous
known
humanpathogen
coronavirus
sarscov
rel
easili
propag
cell
cultur
commonli
use
cell
line
vero
african
green
monkey
kidney
cell
fetal
rhesu
kidney
cell
interest
light
possibl
gastrointestin
patholog
caus
sarscov
human
colon
carcinoma
cell
line
may
also
use
fig
cell
commonli
use
isol
human
respiratori
virus
howev
unsuit
author
abl
isol
sarscov
vero
cell
lower
respiratori
tract
specimen
sputum
bronchoalveolar
lavag
two
frankfurtmain
sar
case
mark
confirm
presenc
sarscov
test
requir
human
sarscov
immun
convalesc
serum
may
use
immunostain
infect
cell
fig
altern
viral
nucleic
acid
test
see
may
perform
cell
cultur
supernat
latter
recommend
use
laboratori
method
sar
diagnosi
may
http
wwwwhointcsrsarslabmethodsen
rel
isol
sarscov
made
sar
outbreak
caus
probabl
sar
case
may
due
fact
mani
laboratori
refrain
viru
isol
due
biosafeti
concern
attempt
long
transport
time
use
patient
sampl
type
low
viral
load
upper
respiratori
tract
may
affect
success
rate
despit
agent
rel
high
degre
resist
variou
environment
condit
advantag
viru
isol
demonstr
presenc
infecti
viru
thu
prove
activ
potenti
infecti
sarscov
infect
patient
cours
neg
cell
cultur
result
exclud
diagnosi
sar
see
viru
isol
furthermor
allow
studi
character
viru
strain
implic
virolog
laboratori
diagnosi
sar
enorm
import
sar
reemerg
inform
might
shed
light
transmiss
virul
differ
strain
sarscov
also
presum
anim
reservoir
intern
agre
viru
isol
suspect
sar
case
perform
least
biosafeti
safeti
level
bsl
condit
postoutbreak
biosafeti
guidelin
handl
sarscov
specimen
cultur
decemb
http
wwwwhointcsr
stress
outbreak
end
juli
singl
laboratori
infect
seem
occur
contrast
sever
incid
sinc
two
without
humantohuman
spread
singapor
septemb
taiwan
decemb
spread
beyond
laboratori
worker
beij
april
therefor
obvious
much
routin
diagnost
workup
suspect
sar
specimen
pose
risk
laboratori
worker
neglect
wellknown
precaut
scientif
work
involv
much
higher
volum
concentr
infecti
materi
possibl
isol
caus
agent
therefor
alway
attempt
suspect
probabl
sar
case
suitabl
facil
avail
wolfgang
preiser
et
al
three
group
simultan
independ
succeed
isol
character
sarscov
publish
method
detect
agent
rna
firstgener
revers
transcript
rt
polymeras
chain
reaction
pcr
target
viral
replicas
gene
detect
pcr
product
via
agaros
gel
electrophoresi
sarscov
rna
sinc
found
variou
clinic
materi
publish
paper
describ
detect
respiratori
secret
lower
upper
respiratori
tract
stool
urin
blood
well
differ
tissu
organ
subsequ
develop
pcr
method
employ
realtim
format
allow
quantif
sarscov
rna
fig
use
method
drosten
et
al
abl
demonstr
high
concentr
viral
rna
molecul
per
ml
sputum
sampl
hand
low
concentr
detect
specimen
upper
respiratori
tract
throat
swab
plasma
acut
phase
ill
howev
faecal
specimen
obtain
late
convalesc
beyond
time
period
strict
isol
patient
usual
recommend
test
posit
patient
hong
kong
peiri
et
al
found
amount
nasopharyng
sarscov
peak
around
day
onset
symptom
time
patient
pcr
posit
nasopharyng
aspir
stool
urin
sampl
current
two
realtim
rtpcr
test
kit
target
viral
replicas
gene
commerci
avail
realart
hpa
coronaviru
lc
kit
artu
hamburg
germani
lightcycl
sarscov
quantif
kit
roch
penzberg
germani
recent
conduct
intern
extern
qualiti
assur
studi
sarscov
nucleic
acid
test
nat
distribut
code
inactiv
sampl
laboratori
differ
countri
seven
posit
sampl
contain
rna
copi
sarscov
strain
frankfurt
per
ml
reconstitut
almost
laboratori
report
correct
result
sampl
contain
viral
rna
copiesml
produc
falseposit
result
three
neg
one
use
commerci
test
kit
found
posit
influenc
diagnost
perform
encourag
outcom
exercis
confirm
success
consider
effort
undertaken
support
laboratori
establish
sarscov
diagnost
test
rapidli
mean
effect
respond
sar
outbreak
european
network
import
viral
infect
enivd
http
www
enivdd
inactiv
standard
prepar
sarscov
avail
diagnost
purpos
improv
insuffici
neg
predict
valu
pcrbase
method
rule
sar
suspect
case
effort
made
increas
methodolog
sensit
besid
increas
volum
patient
sampl
materi
rna
extract
attract
approach
seem
target
viral
nucleocapsid
gene
due
uniqu
transcript
strategi
coronavirus
one
mrna
copi
present
infect
cell
howev
recent
studi
technic
optim
nucleocapsid
inhous
assay
fail
consist
detect
sarscov
rna
clinic
sampl
confirm
sar
patient
overal
posit
rate
around
agreement
result
obtain
group
studi
howev
found
viral
rna
detect
lower
respiratori
tract
sampl
test
method
therefor
conclud
rather
optim
pcr
method
protocol
effort
direct
toward
develop
safe
conveni
method
obtain
specimen
lower
respiratori
tract
suspect
sar
patient
earli
phase
clinic
ill
prior
onset
respiratori
symptom
plasma
may
provid
conveni
safe
altern
sampl
materi
grant
et
al
abl
detect
sarscov
rna
patient
test
within
three
day
onset
fever
studi
confirm
brief
durat
viraemia
sar
case
thu
offer
reassur
blood
transfus
servic
howev
sar
reemerg
larg
scale
method
alreadi
develop
evalu
would
allow
screen
donat
blood
sarscov
rna
clear
studi
cite
numer
othersthat
pcr
rule
presenc
sarscov
patient
certainti
also
risk
falseposit
result
caus
contamin
sampl
laboratori
perform
pcr
trueposit
result
caus
relat
virus
method
low
specif
sarscov
employ
august
consider
confus
mild
respiratori
infect
institut
elderli
canada
initi
report
posit
sarscov
test
later
turn
infect
differ
human
coronaviru
small
number
sar
case
occur
southern
chines
provinc
guangdong
januari
uncertainti
sever
week
true
diagnosi
case
independ
confirm
could
obtain
patient
test
posit
local
reason
issu
clear
guidanc
sampl
handl
test
interpret
laboratori
result
recommend
pcr
result
sarscov
regard
confirm
posit
least
two
differ
clinic
specimen
eg
nasopharyng
stool
type
clinic
specimen
collect
two
day
cours
ill
eg
two
nasopharyng
aspir
test
two
differ
assay
repeat
pcr
use
origin
clinic
sampl
occas
test
yield
posit
result
one
specimen
use
laboratori
method
sar
diagnosi
may
http
wwwwhointcsrsarslabmethodsen
besid
includ
appropri
neg
posit
control
pcr
run
possibl
pcr
inhibit
control
spike
patient
sampl
weak
posit
control
test
parallel
unspik
sampl
postoutbreak
period
truli
posit
sarscov
result
massiv
implic
public
health
etc
second
aliquot
origin
sampl
sent
unopen
nation
sar
refer
laboratori
retest
third
aliquot
retain
use
intern
sar
refer
verif
laboratori
nomin
necessari
summari
pcr
abl
detect
viral
rna
stool
blood
upper
respiratori
tract
sampl
acut
ill
sar
patient
use
commerci
kit
may
increas
reliabl
result
sensit
thu
neg
predict
valu
pcr
requir
improv
unlik
come
chang
pcr
target
gene
region
increas
volum
sampl
rna
extract
test
lower
respiratori
tract
specimen
test
sever
sampl
patient
may
use
approach
nevertheless
diagnosi
sar
current
rule
neg
pcr
result
assay
becam
avail
soon
sarscov
isol
propag
vitro
antibodi
test
allow
assess
quantifi
mean
serial
titrat
patient
sera
abil
neutral
infect
sarscov
although
yet
demonstr
human
nt
titer
may
therefor
correl
clinic
immun
use
assess
humor
immun
anim
studi
furthermor
nt
recommend
mean
rule
nonspecif
antibodi
reactiv
might
occur
test
eg
crossreact
antibodi
direct
nonsar
human
coronavirus
one
disadvantag
nt
limit
institut
cell
cultur
facil
involv
propag
sarscov
ift
first
type
solidphas
antibodi
assay
use
sar
remain
wide
employ
gold
standard
togeth
nt
see
even
exact
natur
newli
isol
agent
known
specif
seroconvers
thu
primari
infect
demonstr
frankfurt
sar
patient
mean
indirect
ift
use
infect
cell
noninfect
cell
control
serum
sampl
obtain
patient
differ
point
time
antihuman
igg
conjug
antibodi
label
fluoresc
dye
fig
peiri
et
al
found
seroconvers
patient
day
onset
symptom
none
antibodi
prior
day
mean
time
period
seroconvers
day
ift
assay
commerci
avail
euroimmun
germani
employ
gammairradi
infect
cell
demonstr
noninfecti
includ
neg
uninfect
cell
control
appropri
posit
neg
control
sera
suitabl
use
condit
ideal
patient
sampl
heat
inactiv
prior
test
exclud
infect
posit
sampl
also
test
serial
dilut
provid
titer
may
help
demonstr
acut
recent
infect
see
number
serolog
test
method
enzym
immunoassay
eia
western
blot
rapid
antibodi
test
develop
employ
infect
cell
lysat
recombin
protein
antigen
even
commerci
avail
howev
none
assay
thoroughli
evalu
yet
mean
comparison
either
ift
nt
therefor
current
imposs
give
wellfound
recommend
regard
use
particularli
well
advertis
rapid
test
caus
much
excit
lay
press
seem
offer
quick
answer
speed
antibodi
test
result
avail
howev
help
commonest
urgent
practic
problem
ie
reliabl
establish
diagnosi
suspect
case
antibodi
test
unsuit
due
appear
antibodi
later
cours
diseas
see
howev
three
week
possibl
contact
sar
patient
eg
travel
health
care
set
antibodi
test
use
tool
exclud
sarscov
infect
taken
place
accord
recommend
serodiagnosi
may
use
normal
retrospect
confirm
diagnosi
sar
either
seroconvers
demonstr
ift
eia
ie
neg
antibodi
test
acut
serum
follow
posit
antibodi
test
convalesc
serum
least
fourfold
rise
antibodi
titer
demonstr
pair
sera
test
parallel
reassuringli
studi
far
show
seroconvers
six
week
begin
ill
almost
sar
patient
result
demonstr
sarscov
antibodi
small
proport
sera
obtain
individu
prior
emerg
sar
remain
confirm
may
reflect
lack
specif
assay
use
rather
preexist
circul
viru
hand
find
sarscov
antibodi
anim
handler
without
histori
clinic
diseas
compat
sar
presum
expos
close
relat
possibl
nonhumanpathogen
coronavirus
isol
differ
speci
anim
southern
china
may
point
possibl
explan
phenomena
howev
studi
found
background
seropreval
sarscov
control
popul
screen
far
therefor
antibodi
test
suit
retrospect
confirm
diagnosi
sar
may
help
elucid
epidemiolog
novel
diseas
cours
unsuit
acut
phase
ill
reliabl
diagnosi
need
urgent
advantag
requir
blood
specimen
probabl
littl
timesensit
patient
beyond
first
week
ill
need
born
mind
intern
case
definit
sar
base
combin
clinic
epidemiolog
factor
requir
specif
virolog
serolog
test
although
evid
sarscov
infect
ad
may
facult
criterion
upgrad
suspect
probabl
case
sinc
clinic
manifest
rate
sarscov
infect
appear
high
epidemiolog
sar
need
revis
howev
much
remain
done
defin
optim
antigen
use
eia
assay
includ
largescal
compar
evalu
panel
welldefin
sera
call
countri
larg
number
sar
case
occur
make
panel
avail
scientif
commun
light
current
avail
inform
regard
unlik
sarscov
continu
circul
human
popul
previous
affect
area
nevertheless
case
guangdong
begin
demonstr
reintroduct
still
unknown
anim
reservoir
possibl
repeat
laboratori
accid
underlin
need
stringent
infect
control
procedur
strict
applic
laboratori
work
agent
place
known
sure
infecti
sarscov
still
exist
therefor
imper
vigil
sar
maintain
defin
three
geograph
zone
accord
presum
risk
potenti
sar
recurr
issu
recommend
sar
surveil
potenti
zone
reemerg
compris
guangdong
adjac
area
animaltohuman
transmiss
sarscov
might
occur
sar
alert
plu
enhanc
sar
surveil
place
special
studi
sarscov
infect
anim
human
popul
conduct
nodal
area
compris
hong
kong
vietnam
singapor
canada
taiwan
experienc
sustain
local
transmiss
spring
entri
numer
person
potenti
zone
reemerg
sar
alert
plu
enhanc
sar
surveil
deem
necessari
low
risk
area
ie
rest
world
surveil
direct
cluster
alert
case
among
health
care
worker
hospit
staff
patient
visitor
health
care
unit
sar
alert
defin
least
two
health
care
worker
develop
clinic
ill
least
three
individu
health
care
worker
andor
hospit
staff
andor
patient
andor
visitor
health
care
unit
develop
hospitalacquir
ill
within
period
fulfil
clinic
case
definit
sar
fulfil
clinic
case
definit
also
mean
altern
diagnosi
fulli
explain
ill
ie
requir
certain
laboratori
test
infecti
agentssuch
influenza
virus
conduct
appropri
case
recogn
enhanc
sar
surveil
otherwis
causal
undiagnos
case
atyp
pneumonia
laboratori
case
definit
develop
base
pcr
antibodi
test
viru
isol
undertaken
nation
region
refer
laboratori
clinic
compat
laboratoryconfirm
case
report
sar
laboratori
workshop
held
octob
geneva
expert
enlarg
intern
laboratori
network
made
sever
recommend
includ
establish
qualiti
assur
programm
standardis
laboratori
test
protocol
establish
sar
refer
verif
laboratori
network
undertak
verif
suspect
case
sarscov
infect
term
refer
requir
laboratori
activ
member
qualiti
assur
programm
requir
sporad
nonepidem
case
suspect
sarscov
infect
verifi
refer
verif
laboratori
extern
countri
case
occur
acquir
assist
develop
panel
posit
sarscov
control
sera
develop
algorithm
assess
need
test
patient
sarscov
infect
base
epidemiolog
geograph
risk
assess
endors
guidelin
biosafeti
laboratori
handl
diagnost
specimen
potenti
contain
sarscov
cultur
sarscov
done
biocontain
level
facil
test
involv
viru
propag
biocontain
level
facil
level
work
practic
test
involv
manipul
live
viru
without
propag
strongli
recommend
countri
maintain
inventori
laboratori
work
sarscov
inventori
cultur
sarscov
laboratori
risk
inappropri
use
scarc
resourc
overwhelm
health
system
unnecessarili
fals
alarm
low
pretest
probabl
sar
taken
account
low
risk
set
postepidem
period
case
investig
respiratori
sampl
ideal
includ
nasopharyng
aspir
provid
full
infect
control
procedur
place
protect
staff
patient
stool
specimen
routin
collect
viru
isol
andor
detect
rtpcr
first
second
week
ill
well
plasma
serum
specimen
earli
second
third
week
demonstr
seroconvers
signific
rise
antibodi
titer
test
acut
convalesc
sera
parallel
laboratori
test
conduct
threetier
system
therefor
clinic
sampl
separ
three
aliquot
time
collect
secur
laboratori
ongo
work
sarscov
one
aliquot
use
local
diagnost
laboratori
second
remain
unopen
use
nation
refer
laboratori
third
aliquot
retain
case
verif
sar
refer
verif
laboratori
becom
necessari
happen
posit
clinic
specimen
report
either
local
diagnost
laboratori
nation
refer
laboratori
regard
interpret
laboratori
result
specimen
found
posit
pcr
viru
isol
requir
confirm
second
previous
unopen
aliquot
specimen
second
laboratori
second
independ
collect
specimen
genom
region
amplifi
pcr
specif
sarscov
conserv
amongst
known
coronavirus
pcr
product
sequenc
verifi
presenc
sarscov
fourfold
greater
rise
antibodi
titer
parallel
test
ift
eia
use
wellcharacteris
antigen
anoth
serolog
test
acut
convalesc
phase
sera
collect
least
day
apart
indic
suspect
case
confirm
nt
mandatori
possibl
antibodi
crossreact
human
coronavirus
purpos
guidelin
clearli
ensur
maximum
specif
laboratori
result
order
avoid
fals
alarm
would
put
unnecessari
stress
health
system
might
long
run
lead
lower
vigil
sar
reemerg
larger
scale
confirmatori
requir
might
modifi
despit
rapid
discoveri
caus
agent
earli
develop
diagnost
test
progress
laboratori
diagnosi
sar
somewhat
slower
might
expect
although
numer
pcrbase
assay
develop
technic
superb
still
test
could
use
rule
diagnosi
sar
suspect
case
due
compar
low
viru
excret
earli
cours
sar
current
postoutbreak
phase
thorough
evalu
suspect
case
agent
known
caus
atyp
pneumonia
influenza
parainfluenza
virus
legionella
pneumophila
mycoplasma
pneumonia
etc
even
import
furthermor
decis
made
also
includ
sar
differenti
diagnosi
necessit
thorough
uptod
inform
patient
person
work
travel
histori
well
current
epidemiolog
situat
worldwid
recommend
made
see
check
updat
follow
meticul
two
laboratoryacquir
sar
case
singapor
taiwan
second
half
sporad
sar
case
report
guangdong
begin
demonstr
function
surveil
alert
system
recommend
newli
emerg
case
may
detect
time
fashion
confirm
laboratori
test
includ
independ
confirm
spread
thu
prevent
recent
laboratoryassoci
case
beij
april
howev
cast
doubt
qualiti
local
surveil
system
littl
one
year
lot
learn
novel
viru
diseas
caus
undoubtedli
much
remain
understood
avail
prudent
applic
sarscov
laboratori
test
allow
address
sever
import
question
also
becom
clear
much
remain
done
given
littl
attent
previous
known
human
coronavirus
receiv
human
virolog
laboratori
diagnosi
sar
even
offer
chanc
improv
understand
epidemiolog
clinic
relev
develop
appli
suitabl
test
time
howev
great
care
exercis
use
sarscov
test
clinic
set
prerequisit
stay
uptod
current
recommend
issu
relev
nation
organ
scientif
bodi
recent
meet
scientif
research
advisori
committe
sar
identifi
sever
prioriti
issu
laboratori
research
includ
evalu
standard
current
futur
diagnost
test
sar
improv
serolog
test
respect
specif
sensit
studi
natur
crossreact
differ
coronavirus
determin
import
viru
strain
variat
diagnost
test
find
new
technolog
appli
develop
inexpens
sensit
specif
laboratori
test
reliabl
first
day
ill
